purpleDx

electronRx launches smartphone-based lung monitoring through digital biomarkers

Medical technology company electronRx has developed a smartphone-based system for monitoring lung function in patients with chronic respiratory diseases (CRDs). The purpleDx app, which will launch at CES 2025 in Las Vegas, transforms mobile phones into diagnostic tools by capturing and analysing digital biomarkers through the device’s camera.

colorectal cancer

Global study reveals alarming rise in early-onset colorectal cancer

Early-onset colorectal cancer incidence rates are increasing in more than half of the countries studied worldwide, with the steepest rises seen in New Zealand, Chile, and Puerto Rico, according to comprehensive new research published in The Lancet Oncology [1].  

Siemens_Healthineers_Naeotom Alpha CT

Siemens expands photon-counting CT portfolio with new class of scanners

Three years after launching the world’s first photon-counting computed tomography scanner, Siemens Healthineers has expanded its portfolio with two new systems: the dual-source Naeotom Alpha.Pro and the single-source Naeotom Alpha.Prime. These innovations promise enhanced diagnostic capabilities through superior image quality at lower radiation doses, with potential to change clinical pathways. Callan Emery attended the launch […]

Samsung RSNA 2024

Samsung expands diagnostic imaging portfolio with focus on paediatric care

Samsung Electronics Health and Medical Equipment Business and Samsung Medison have unveiled new diagnostic imaging equipment at the 2024 Radiological Society of North America (RSNA) conference, with a significant focus on paediatric care solutions.

Mindray Resona I8 ultrasound

Mindray expands radiology portfolio with new ultrasound system

At RSNA 2024 in Chicago, Mindray announced an expansion of its Resona-Series radiology portfolio with the introduction of a new shared service imaging system, the Resona I8 ultrasound machine. The system, which utilises the company’s proprietary Zone Sonography Technology+ (ZST+) software-based beamformer, aims to address the evolving needs of diagnostic imaging departments and practices.

Philips CT-5000

Philips enhances clinical decision support with AI-driven CT workflow solutions

Royal Philips has announced significant improvements in clinical decision-support capabilities through artificial intelligence and workflow automation in their CT 5300 system. The system, which makes its North American debut at RSNA 2024, incorporates comprehensive AI-enabled ‘Precise’ software solutions designed to optimise the CT workflow process.

GE HealthCare Aurora, a new dual-head SPECT/CT system

GE Healthcare unveils new dual-head SPECT/CT system with AI capabilities

At RSNA 2024, GE HealthCare presented Aurora, a new dual-head SPECT/CT system that integrated advanced CT capabilities with nuclear medicine imaging functionality. The system, which received CE marking but remained pending FDA 510(k) clearance, was designed to expand the range of CT procedures typically available in hybrid systems.

Konica Minolta Healthcare

Konica Minolta introduces range of digital radiography solutions at RSNA 2024

Konica Minolta Healthcare Americas has unveiled several digital radiography (DR) solutions at RSNA 2024, focusing on workflow optimisation and resource management. The company’s latest developments include FDA-cleared Bone Suppression Imaging (BSI) for chest X-rays, designed to enhance lung visualisation by suppressing rib and clavicle structures. BSI will be available as a standalone solution compatible with […]

Interim Diagnostic Imaging mobile MRI trailer

Interim Diagnostic Imaging introduces expanded-width mobile MRI scanner trailer

Mobile diagnostic imaging provider Interim Diagnostic Imaging (IDI) and its parent company Modular Devices have introduced what they report to be the first 3-metre (10-foot) wide mobile magnetic resonance imaging (MRI) scanner trailer. At 10 foot wide, this expanded-width trailer is 2 foot wider than other mobile MRI trailers on the market.

gene therapy

New RNA technology enables gene therapy for previously untreatable muscular dystrophies

A groundbreaking RNA-based technology allows therapeutic genes that are too large for conventional delivery methods to be successfully transported into cells, offering new hope for treating muscular dystrophies and other genetic disorders caused by mutations in large genes.